Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/09/1998 | EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
12/09/1998 | EP0882128A1 Cell-based assay |
12/09/1998 | EP0882127A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates |
12/09/1998 | EP0882065A2 Novel human metabotropic glutamate receptor |
12/09/1998 | EP0796088A4 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
12/09/1998 | EP0689599B1 Chimeric selectins by exchange of domains - uses thereof |
12/09/1998 | EP0332667B2 Vector for integration site independent gene expression in mammalian host cells |
12/08/1998 | US5847257 Transgenic mouse deficient in T-cells |
12/08/1998 | US5847082 Terminal complement inhibitor fusion proteins |
12/08/1998 | US5846952 Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery |
12/08/1998 | US5846946 Compositions and methods for administering Borrelia DNA |
12/08/1998 | US5846935 Modified ciliary neurotrophic factors |
12/08/1998 | US5846928 Method for treating cancer patients |
12/08/1998 | US5846829 Method and apparatus for growing plant cells |
12/08/1998 | US5846827 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL |
12/08/1998 | US5846826 Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides |
12/08/1998 | US5846825 Feline derived T-cell lines for producing FIV |
12/08/1998 | US5846823 Expression of human D4 dopamine receptors in stable cell lines |
12/08/1998 | US5846807 Media compositions for three-dimensional mammalian tissue growth under microgravity culture conditions |
12/08/1998 | US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ |
12/08/1998 | US5846796 Blood-borne mesenchymal cells |
12/08/1998 | US5846795 RNA transformation vector |
12/08/1998 | US5846782 Targeting adenovirus with use of constrained peptide motifs |
12/08/1998 | US5846779 Nucleic acids encoding murine UCP3 genes |
12/08/1998 | US5846774 Chlorella virus promoters |
12/08/1998 | US5846773 Single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof |
12/08/1998 | US5846766 Oxytocin receptor and DNA coding therefor |
12/08/1998 | US5846764 Materials and methods relating to proteins that interact with casein kinase I |
12/08/1998 | US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase |
12/08/1998 | US5846725 Methods for identifying cisplatin resistant tumor cells |
12/08/1998 | US5846712 Tumor suppressor gene, HIC-1 |
12/08/1998 | US5846711 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
12/08/1998 | US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
12/08/1998 | US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
12/08/1998 | US5846536 Restoration of normal phenotype in cancer cells |
12/08/1998 | US5846533 Antibodies specific for native PrPSc |
12/08/1998 | US5846529 Infusion of neutrophil precursors for treatment of neutropenia |
12/08/1998 | US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence |
12/08/1998 | US5846527 Continuous cell line and vaccine against avian coccidia |
12/04/1998 | CA2233587A1 Novel compounds |
12/03/1998 | WO1998054366A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
12/03/1998 | WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases |
12/03/1998 | WO1998054344A2 Modulators of morphogen expression and methods of identifying the same |
12/03/1998 | WO1998054342A1 Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires) |
12/03/1998 | WO1998054340A1 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
12/03/1998 | WO1998054336A1 Method for mass production of antimicrobial peptide |
12/03/1998 | WO1998054335A1 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna |
12/03/1998 | WO1998054330A1 Methods of in situ modification of plant genes |
12/03/1998 | WO1998054324A1 Human multiple endocrine neoplasia type 1 protein |
12/03/1998 | WO1998054322A1 Osf2/cbfa1 compositions and methods of use |
12/03/1998 | WO1998054321A1 New human dp1 homolog |
12/03/1998 | WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
12/03/1998 | WO1998054316A1 Sodium channel receptor |
12/03/1998 | WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides |
12/03/1998 | WO1998054301A2 Transplants for myocardial scars and method and cellular preparations therefor |
12/03/1998 | WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
12/03/1998 | WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR |
12/03/1998 | WO1998054217A1 Angiostatin fragments and method of use |
12/03/1998 | WO1998054214A2 Hypersensitive response elicitor fragments and uses thereof |
12/03/1998 | WO1998054213A2 Neurotrophic factor receptors |
12/03/1998 | WO1998054206A1 32 human secreted proteins |
12/03/1998 | WO1998054202A1 Human tumor necrosis factor receptor tr10 |
12/03/1998 | WO1998054199A1 Tissue plasminogen activator-like protease |
12/03/1998 | WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration |
12/03/1998 | WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA |
12/03/1998 | WO1998045712A3 20 human secreted proteins |
12/03/1998 | WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies |
12/03/1998 | WO1998045331A3 Anti-vegf antibodies |
12/03/1998 | WO1998042739A3 Secreted proteins and polynucleotides encoding them |
12/03/1998 | WO1998040486A3 Secreted proteins and polynucleotides encoding them |
12/03/1998 | WO1998039427A3 Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters |
12/03/1998 | WO1998035027A3 Human nerve growth factor exon 1 and exon 3 promoters |
12/03/1998 | WO1998033916A3 Secreted proteins and polynucleotides encoding them |
12/03/1998 | DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes |
12/03/1998 | CA2358161A1 Organisms containing insecticidal proteins |
12/03/1998 | CA2292790A1 Human tumor necrosis factor receptor tr10 |
12/03/1998 | CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
12/03/1998 | CA2291698A1 Osf2/cbfa1 compositions and methods of use |
12/03/1998 | CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides |
12/03/1998 | CA2291510A1 Modulators of morphogen expression and methods of identifying the same |
12/03/1998 | CA2291482A1 Tissue plasminogen activator-like protease |
12/03/1998 | CA2291449A1 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna |
12/03/1998 | CA2291221A1 32 human secreted proteins |
12/03/1998 | CA2290954A1 Human multiple endocrine neoplasia type 1 protein |
12/03/1998 | CA2290943A1 New human dp1 homolog |
12/03/1998 | CA2289905A1 Hypersensitive response elicitor fragments and uses thereof |
12/03/1998 | CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide |
12/03/1998 | CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33 |
12/02/1998 | EP0881298A2 Metalloporoteases |
12/02/1998 | EP0881297A2 Histidine kinase |
12/02/1998 | EP0881294A2 HOEFCC11, a HAS2 splicing variant |
12/02/1998 | EP0881292A2 Streptocococcus pneumoniae peptide release factor |
12/02/1998 | EP0881289A2 Novel 7TM receptor (H2CAA71) |
12/02/1998 | EP0880693A1 Creation and use of multiple gradients in electrophoresis in gel slabs and in capillaries |
12/02/1998 | EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
12/02/1998 | EP0880594A1 Retroviral vector and its use in gene therapy |
12/02/1998 | EP0880593A1 Improvements in or relating to gene expression |
12/02/1998 | EP0880590A1 Esterases |
12/02/1998 | EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
12/02/1998 | EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |